ALK and non-small cell lung carcinoma: We here demonstrate the potential use of DBP to determine the cytotoxicity of ALK inhibitors and the anti-apoptotic programs involved in DTP cancer cell survival in ALK-rearranged NSCLC that we believe could impact its treatment in the future.